- Home
- SMC vs LXRX Comparison
SMC vs LXRX Comparison
Compare SMC & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMC
- LXRX
- Stock Information
- Founded
- SMC 2009
- LXRX 1995
- Country
- SMC United States
- LXRX United States
- Employees
- SMC N/A
- LXRX N/A
- Industry
- SMC
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- SMC
- LXRX Health Care
- Exchange
- SMC NYSE
- LXRX Nasdaq
- Market Cap
- SMC 398.9M
- LXRX 352.5M
- IPO Year
- SMC 2012
- LXRX 2000
- Fundamental
- Price
- SMC $34.96
- LXRX $0.71
- Analyst Decision
- SMC
- LXRX Buy
- Analyst Count
- SMC 0
- LXRX 2
- Target Price
- SMC N/A
- LXRX $6.00
- AVG Volume (30 Days)
- SMC 82.1K
- LXRX 5.4M
- Earning Date
- SMC 02-05-2025
- LXRX 11-12-2024
- Dividend Yield
- SMC N/A
- LXRX N/A
- EPS Growth
- SMC N/A
- LXRX N/A
- EPS
- SMC N/A
- LXRX N/A
- Revenue
- SMC $450,857,000.00
- LXRX $5,229,000.00
- Revenue This Year
- SMC N/A
- LXRX $886.38
- Revenue Next Year
- SMC N/A
- LXRX $181.58
- P/E Ratio
- SMC N/A
- LXRX N/A
- Revenue Growth
- SMC 7.80
- LXRX 886.60
- 52 Week Low
- SMC $15.56
- LXRX $0.62
- 52 Week High
- SMC $40.75
- LXRX $3.73
- Technical
- Relative Strength Index (RSI)
- SMC 39.14
- LXRX 36.95
- Support Level
- SMC $34.23
- LXRX $0.66
- Resistance Level
- SMC $35.64
- LXRX $0.85
- Average True Range (ATR)
- SMC 1.10
- LXRX 0.10
- MACD
- SMC -0.35
- LXRX 0.02
- Stochastic Oscillator
- SMC 17.51
- LXRX 23.67
About SMC SUMMIT MIDSTREAM CORPORATION
Summit Midstream Corp is a value-driven corporation focused on developing, owning and operating midstream energy infrastructure assets strategically located in unconventional resource basins, primarily shale formations, in the continental U.S. It currently operates natural gas, crude oil and produced water gathering systems in four unconventional resource basins: the Williston Basin in North Dakota, which includes the Bakken and Three Forks shale formations; the Denver-Julesburg Basin, which includes the Niobrara and Codell shale formations in Colorado and Wyoming; the Fort Worth Basin in Texas, which includes the Barnett Shale formation; and the Piceance Basin in Colorado, which includes the liquids-rich Mesaverde formation as well as the emerging Mancos and Niobrara Shale formations.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.